美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=DURANEST
符合检索条件的记录共6
1 页 当前第 1 页  返回检索页
1药品名称DURANEST
申请号017751产品号003
活性成分ETIDOCAINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ASTRAZENECA LP
2药品名称DURANEST
申请号017751产品号004
活性成分EPINEPHRINE; ETIDOCAINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格0.005MG/ML;0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ASTRAZENECA LP
3药品名称DURANEST
申请号017751产品号005
活性成分ETIDOCAINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格1% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ASTRAZENECA LP
4药品名称DURANEST
申请号017751产品号006
活性成分EPINEPHRINE BITARTRATE; ETIDOCAINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格0.005MG/ML;1% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ASTRAZENECA LP
5药品名称DURANEST
申请号017751产品号007
活性成分EPINEPHRINE BITARTRATE; ETIDOCAINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格0.005MG/ML;1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ASTRAZENECA LP
6药品名称DURANEST
申请号021384产品号001
活性成分EPINEPHRINE BITARTRATE; ETIDOCAINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格0.005MG/ML;1.5%
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构DENTSPLY PHARMACEUTICAL